DGX vs ROIV · P/E 22, rev $5.94B vs rev $8.3M
Quest Diagnostics Incorporated (DGX) versus Roivant Sciences Ltd (ROIV) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 71.6% from 2025-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. ROIV currently screens at market cap $7.47B.
Not investment advice. Open the DGX and ROIV stock pages for the full models.
Not investment advice.